HANIF KHAN: Open Payments
NPI 1609030147 · CANTON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$955 in 28 payments from 10 companies in 2025. Trend: 2023 $641 · 2024 $438 · 2025 $955
Food & beverage: $955
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 7 | $320 |
| Janssen Pharmaceuticals, Inc | 5 | $208 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $139 |
| E.R. Squibb & Sons, L.L.C. | 4 | $77 |
| Alkermes, Inc. | 3 | $62 |
| Supernus Pharmaceuticals, Inc. | 2 | $40 |
| Lundbeck LLC | 2 | $34 |
| Indivior Inc. | 1 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
Products named: INVEGA SUSTENNA, REXULTI, ABILIFY MAINTENA, CAPLYTA, COBENFY, Qelbree, ABILIFY ASIMTUFII, ARISTADA.
Industry payments across MI — which companies pay providers there.
